Related Experiment Video
Updated: Jun 27, 2026

08:20
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
In vitro drug sensitivity testing in Plasmodium vivax
Walther H Wernsdorfer1, Oumaporn Tasanor, Gunther Wernsdorfer
1Institute of Specific Prophylaxis and Tropical Medicine, Centre for Physiology and Pathophysiology, Medical University of Vienna, Austria. walter.wernsdorfer@meduniwien.ac.at
Wiener Klinische Wochenschrift
|January 1, 2008
Summary
Developing drug sensitivity tests for Plasmodium vivax is possible with short-term in vitro cultivation. A novel population-based assay accurately measures drug efficacy across parasite stages, aiding antimalarial development.
Area of Science:
- Malariology
- Parasitology
- Infectious Diseases
Background:
- Plasmodium vivax poses challenges for drug sensitivity testing due to variable parasite stages in peripheral blood.
- Existing methods may be influenced by parasite population dynamics, affecting accuracy.
Purpose of the Study:
- To develop a reliable in vitro drug sensitivity assay for Plasmodium vivax.
- To establish a method that accounts for parasite age composition and progression.
Main Methods:
- Short-term in vitro cultivation of asexual erythrocytic stages of Plasmodium vivax.
- Development of a population-based test system to monitor parasite progression under drug pressure.
- Determination of inhibitory concentrations (IC) across various parasite stages.
Main Results:
- The in vitro cultivation allows for the observation of mature schizonts.
- A population-based test system demonstrated precise results, even at higher IC ranges.
- The assay effectively reflects parasite population age and progression, unaffected by trophozoite numbers.
Conclusions:
- A novel population-based assay enables accurate drug sensitivity testing for Plasmodium vivax.
- This method can identify stage-specific antimalarial drug effects.
- The findings support the development of more effective antimalarial therapies for P. vivax infections.

